GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | November 28, 2024 |
PDB ID ▼ | UniProt ID | Title | Descriptor |
---|---|---|---|
1FZB | P02671 | CRYSTAL STRUCTURE OF CROSSLINKED FRAGMENT D | |
1FZB | P02675 | CRYSTAL STRUCTURE OF CROSSLINKED FRAGMENT D | |
1FZB | P02679 | CRYSTAL STRUCTURE OF CROSSLINKED FRAGMENT D | |
1FZB | 1FZB | CRYSTAL STRUCTURE OF CROSSLINKED FRAGMENT D | |
1FZA | P02671 | CRYSTAL STRUCTURE OF FIBRINOGEN FRAGMENT D | |
1FZA | P02675 | CRYSTAL STRUCTURE OF FIBRINOGEN FRAGMENT D | |
1FZA | P02679 | CRYSTAL STRUCTURE OF FIBRINOGEN FRAGMENT D | |
1FYU | P16404 | Crystal structure of erythrina corallodendron lectin in hexagonal crystal form | |
1FYT | P01903 | CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1 | |
1FYT | P04229 | CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1 | |
1FYT | P03437 | CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1 | |
1FYT | RWHUAC | CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1 | |
1FYT | P01850 | CRYSTAL STRUCTURE OF A COMPLEX OF A HUMAN ALPHA/BETA-T CELL RECEPTOR, INFLUENZA HA ANTIGEN PEPTIDE, AND MHC CLASS II MOLECULE, HLA-DR1 | |
1FY3 | P20160 | [G175Q]HBP, A mutant of human heparin binding protein (CAP37) | |
1FY1 | P20160 | [R23S,F25E]HBP, A MUTANT OF HUMAN HEPARIN BINDING PROTEIN (CAP37) | |
1FX8 | P11244 | CRYSTAL STRUCTURE OF THE E. COLI GLYCEROL FACILITATOR (GLPF) WITH SUBSTRATE GLYCEROL | |
1FX5 | P22972 | CRYSTAL STRUCTURE ANALYSIS OF ULEX EUROPAEUS LECTIN I | |
1FWV | A48925 | CRYSTAL STRUCTURE OF THE CYSTEINE-RICH DOMAIN OF MANNOSE RECEPTOR COMPLEXED WITH 3-SO4-LEWIS(A) | |
1FWU | A48925 | CRYSTAL STRUCTURE OF THE CYSTEINE-RICH DOMAIN OF MANNOSE RECEPTOR COMPLEXED WITH 3-SO4-LEWIS(X) | |
1FWT | O66496 | AQUIFEX AEOLICUS KDO8P SYNTHASE IN COMPLEX WITH PEP, E4P AND CADMIUM | |
1FVM | NOR00681 | Complex of vancomycin with DI-acetyl-LYS-D-ALA-D-ALA | |
1FVM | 1FVM | Complex of vancomycin with DI-acetyl-LYS-D-ALA-D-ALA | |
1FV3 | P04958 | THE HC FRAGMENT OF TETANUS TOXIN COMPLEXED WITH AN ANALOGUE OF ITS GANGLIOSIDE RECEPTOR GT1B | |
1FV2 | P04958 | The Hc fragment of tetanus toxin complexed with an analogue of its ganglioside receptor GT1B | |
1FUJ | P24158 | PR3 (MYELOBLASTIN) | |
1FU8 | P00489 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN | |
1FU7 | P00489 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN | |
1FU4 | P00489 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN | |
1FTY | P00489 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN | |
1FTW | P00489 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN | |
1FTQ | P00489 | STRUCTURES OF GLYCOGEN PHOSPHORYLASE-INHIBITOR COMPLEXES AND THE IMPLICATIONS FOR STRUCTURE-BASED DRUG DESIGN | |
1FSU | P15848 | Crystal Structure of 4-Sulfatase (human) | N-ACETYLGALACTOSAMINE-4-SULFATASE |
1FSS | P04058 | ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH FASCICULIN-II | |
1FSS | P01403 | ACETYLCHOLINESTERASE (E.C. 3.1.1.7) COMPLEXED WITH FASCICULIN-II | |
1FSG | Q26997 | TOXOPLASMA GONDII HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE COMPLEXED WITH 9-DEAZAGUANINE, ALPHA-D-5-PHOSPHORIBOSYL-1-PYROPHOSPHATE (PRPP) AND TWO MG2+ IONS | |
1FSA | P00636 | THE T-STATE STRUCTURE OF LYS 42 TO ALA MUTANT OF THE PIG KIDNEY FRUCTOSE 1,6-BISPHOSPHATASE EXPRESSED IN E. COLI | |
1FS5 | P0A759 | A DISCOVERY OF THREE ALTERNATE CONFORMATIONS IN THE ACTIVE SITE OF GLUCOSAMINE-6-PHOSPHATE ISOMERASE | |
1FS4 | P00489 | Structures of glycogen phosphorylase-inhibitor complexes and the implications for structure-based drug design | GLYCOGEN PHOSPHORYLASE (E.C.2.4.1.1) |
1FRZ | P0A759 | GLUCOSAMINE-6-PHOSPHATE DEAMINASE FROM E.COLI, R CONFORMER. COMPLEXED WITH THE ALLOSTERIC ACTIVATOR N-ACETYL-GLUCOSAMINE-6-PHOSPHATE AT 2.2 A RESOLUTION | |
1FRT | P13599 | CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC | FC RECEPTOR (NEONATAL) COMPLEXED WITH FC (IGG) (FC/FCRN COMPLEX) |
1FRT | P07151 | CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC | FC RECEPTOR (NEONATAL) COMPLEXED WITH FC (IGG) (FC/FCRN COMPLEX) |
1FRT | 243866 | CRYSTAL STRUCTURE OF THE COMPLEX OF RAT NEONATAL FC RECEPTOR WITH FC | FC RECEPTOR (NEONATAL) COMPLEXED WITH FC (IGG) (FC/FCRN COMPLEX) |
1FRP | P00636 | CRYSTAL STRUCTURE OF FRUCTOSE-1,6-BISPHOSPHATASE COMPLEXED WITH FRUCTOSE-2,6-BISPHOSPHATE, AMP AND ZN2+ AT 2.0 ANGSTROMS RESOLUTION. ASPECTS OF SYNERGISM BETWEEN INHIBITORS | |
1FQD | P02928 | CRYSTAL STRUCTURE OF MALTOTETRAITOL BOUND TO CLOSED-FORM MALTODEXTRIN BINDING PROTEIN | |
1FQC | P02928 | CRYSTAL STRUCTURE OF MALTOTRIOTOL BOUND TO CLOSED-FORM MALTODEXTRIN BINDING PROTEIN | |
1FQB | P02928 | STRUCTURE OF MALTOTRIOTOL BOUND TO OPEN-FORM MALTODEXTRIN BINDING PROTEIN IN P2(1)CRYSTAL FORM | |
1FQA | P02928 | STRUCTURE OF MALTOTETRAITOL BOUND TO OPEN-FORM MALTODEXTRIN BINDING PROTEIN IN P2(1)CRYSTAL FORM | |
1FQ9 | P09038 | CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX | |
1FQ9 | P11362 | CRYSTAL STRUCTURE OF A TERNARY FGF2-FGFR1-HEPARIN COMPLEX | |
1FQ8 | P07267 | X-RAY STRUCTURE OF DIFLUOROSTATINE INHIBITOR CP81,198 BOUND TO SACCHAROPEPSIN |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024